35 results for "Shih-Feng Cho"
Showing 1–20 · 0.46 seconds · RSS
-
Journal Article
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1
Immunomodulatory drugs and monoclonal antibody-based immunotherapies have significantly improved the prognosis of the patients with multiple myeloma (MM) in the recent years. These new classes of reagents target malignant plasma cells (PCs) and further modulate the immune microenvironment, which…
-
Journal Article
Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy
The approval of the first two monoclonal antibodies targeting CD38 (daratumumab) and SLAMF7 (elotuzumab) in late 2015 for treating relapsed and refractory multiple myeloma (RRMM) was a critical advance for immunotherapies for multiple myeloma (MM). Importantly, the outcome of patients continues to…
-
Journal Article
Bispecific antibodies in multiple myeloma treatment: A journey in progress
The incorporation of novel agents and monoclonal antibody-based therapies into the treatment of multiple myeloma (MM) has significantly improved long-term patient survival. However, the disease is still largely incurable, with high-risk patients suffering shorter survival times, partly due to…
-
Journal Article
Docetaxel for High-Grade Mucoepidermoid Carcinoma of the Lung
Mucoepidermoid carcinoma is considered to be one of the salivary gland-type cancers, which seldom originate from the lung. Herein, we report a 69-year-old female with primary pulmonary high-grade mucoepidermoid carcinoma. The disease progressed rapidly and reached an unresectable status. We treated…
-
Journal Article
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with a 5-year mortality rate of ~50%. The development of immunotherapies has improved the survival of patients with HNSCC, but, the long-term prognosis of patients with recurrent or metastatic HNSCC remains poor…
-
Journal Article
Large Renal Cell Carcinoma with Multiple Metastases Presenting as Low Back Pain
Renal cell carcinoma (RCC) is a highly lethal genitourinary malignancy due to infrequent early diagnosis, which responds poorly to conventional immune therapy, chemotherapy or radiotherapy in metastatic disease. There have been great advances in the understanding of the molecular mechanisms of RCC…
-
Journal Article
Rare Presentation of Prostate Cancer Mimicking Malignant Lymphoma with Generalized Lymphadenopathy
Prostate cancer typically metastasizes to bones and regional lymph nodes. Generalized lymphadenopathy is a rare manifestation of metastatic prostate cancer. We report a case of prostate cancer in a 65-year-old male with initial presentation of generalized lymphadenopathy and no urinary symptoms…
-
Journal Article
Utilizing Advanced Molecular Analysis to Tailor Treatment for Cancer of Unknown Primary Site: A Case Report and Lecture Review
Cancer of unknown primary site (CUP) presents as metastatic lesions without an identified primary tumor despite extensive evaluation. Because the primary cancer type cannot be determined, there are no standard treatments, leading to challenges in the treatment and suboptimal clinical outcomes…
-
Journal Article
HIV-negative disseminated Kaposi’s sarcoma in a Taiwanese patient
Kaposi’s sarcoma is a common malignancy associated with HIV/AIDS. Herein, we describe the case of a 26-year-old man who presented with bilateral neck and inguinal lymphadenopathy, a massive tumor on the gum, and a nodule over the left eye. A series of tests, including tumor biopsies, were…
-
Journal Article Full text
Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma
2015 was a groundbreaking year for the multiple myeloma community partly due to the breakthrough approval of the first two monoclonal antibodies in the treatment for patients with relapsed and refractory disease. Despite early disappointments, monoclonal antibodies targeting CD38 (daratumumab) and…
-
Journal Article Full text
Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study
Background: The purpose of this study was to investigate the association between previous exposure to statins and the risk of non-Hodgkin lymphoma (NHL). Methods: This nationwide population-based case–control study was conducted using the National Health Insurance Research Database of Taiwan. The…
Also available at: DOAJ
-
Journal Article
Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma
The aim of this study was to investigate the role of 2-fluorine-18-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in the initial staging and prediction of bone marrow involvement in patients with newly diagnosed lymphoma. A total of 185 patients with…
-
Journal Article
Huge soft tissue PEComa with aggressive lung and bone metastases
Perivascular epithelioid cell tumors (PEComas) are uncommon mesenchymal tumors characterized by the presence of both myogenic and melanocytic markers, and huge soft tissue PEComas are even rarer. With low prevalence, there has been no common consensus therapy in the past and the treatment response…
-
Journal Article Full text
Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study
Background This study aimed to analyze the clinical outcomes associated with patients with recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC) who received cetuximab-based chemotherapy in a real-world clinical setting. Methods Clinical data were extracted from RM HNSCC patients…
-
Journal Article
Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma
Abstract The present study aimed to elucidate the prognostic mutation signature (PMS) associated with long-term survival in a diffuse large B-cell lymphoma (DLBCL) cohort. All data including derivation and validation cohorts were retrospectively retrieved from The Cancer Genome Atlas (TCGA)…
-
Journal Article
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation
Abstract We here defined the impacts of γ-secretase inhibitors (GSIs) on T-cell-dependent BCMA-specific multiple myeloma (MM) cell lysis and immunomodulatory effects induced by bispecific antibodies (BisAbs). GSIs-induced membrane BCMA (mBCMA) accumulation reached near maximum within 4 h and…